FDA Interoperability Designation-Creating Options for People With Diabetes and Pump Companies: Regulatory, Technological, and Commercial Perspectives

David C Klonoff; Cindy N Ho; Alessandra Ayers; Aiman Abdel-Malek

doi:10.1177/19322968241271304

FDA Interoperability Designation-Creating Options for People With Diabetes and Pump Companies: Regulatory, Technological, and Commercial Perspectives

J Diabetes Sci Technol. 2024 Sep 10:19322968241271304. doi: 10.1177/19322968241271304. Online ahead of print.

Authors

David C Klonoff^{1

2}, Cindy N Ho², Alessandra Ayers², Aiman Abdel-Malek^{3

4}

Affiliations

¹ Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA.
² Diabetes Technology Society, Burlingame, CA, USA.
³ Thirdwayv Inc., Irvine, CA, USA.
⁴ Apex Medical Ai Inc., Irvine, CA, USA.

No abstract available

Keywords: AID system; algorithm; alternate controller enabled pump; diabetes technology; interoperable automated glycemic controller; interoperable continuous glucose monitor.

Publication types

Editorial